(89)Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

RATIONALE: Epidermal growth factor receptor (EGFR) upregulation is associated with enhanced proliferation and drug resistance in a number of cancers. Nimotuzumab is a humanized monoclonal antibody with high affinity for EGFR. The objective of this study was to determine if (89)Zr-DFO-nimotuzumab cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Chekol, Rufael, Solomon, Viswas Raja, Alizadeh, Elahe, Bernhard, Wendy, Fisher, Darrell, Hill, Wayne, Barreto, Kris, DeCoteau, John Francis, Parada, Angel Casaco, Geyer, Clarence Ronald, Fonge, Humphrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908310/
https://www.ncbi.nlm.nih.gov/pubmed/29682209
http://dx.doi.org/10.18632/oncotarget.24965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908310/
https://www.ncbi.nlm.nih.gov/pubmed/29682209
http://dx.doi.org/10.18632/oncotarget.24965

Ejemplares similares